New assay to detect genetic abnormalities in sarcomas outperforms conventional techniques
(Elsevier) A report in The Journal of Molecular Diagnostics describes a new assay, anchored multiplex PCR (AMP)-based targeted next-generation-sequencing (NGS), with superior diagnostic utility compared to conventional techniques. This includes the ability to analyze numerous target genes simultaneously and identify new fusion partners. In four cases, the assay diagnosed sarcoma in samples deemed falsely negative by conventional tests. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 20, 2018 Category: Cancer & Oncology Source Type: news
Solid tumors targeted in new CAR T-Cell immunotherapy trial
(Seattle Children's) Seattle Children's has opened a chimeric antigen receptor (CAR) T-cell immunotherapy trial for children and young adults with relapsed or refractory non-central nervous system EGFR-expressing solid tumors. In the phase 1 trial, STRIvE-01, cancer-fighting CAR T cells will target the EGFR protein expressed in many childhood sarcoma, kidney and neuroblastoma tumors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 7, 2018 Category: International Medicine & Public Health Source Type: news
MGH team defines the mechanisms of action of key genetic abnormality in Ewing sarcoma
(Massachusetts General Hospital) A Massachusetts General Hospital research team has used epigenome editing tools to investigate how the genetic abnormality that drives Ewing sarcoma -- the second most common bone cancer in children and young adults -- unleashes tumor growth. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 2, 2018 Category: Cancer & Oncology Source Type: news
Study: Paclitaxel Best for HIV-Related Kaposi's Sarcoma
(MedPage Today) -- Other chemotherapies fall behind in resource-limited setting (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - July 29, 2018 Category: Dermatology Source Type: news
Can deep learning monitor lesions on F-18 NaF PET/CT?
Deep learning can classify bone lesions found on F-18 sodium fluoride (NaF)...Read more on AuntMinnie.comRelated Reading:
Group uses AI to assess mammo interpretation bias
SNMMI: AI enables stress-first SPECT MPI protocol
SNMMI: Early prostate cancer therapy extends lives
SNMMI: AI can predict survival in sarcoma patients
AI algorithm can classify bone lesions on PET/CT images (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 5, 2018 Category: Radiology Source Type: news
Infographic: What to know about sarcoma
Learn more about sarcoma. Other health tip infographics: mayohealthhighlights.startribune.com? (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 4, 2018 Category: Databases & Libraries Source Type: news
How will machine learning affect radiology practice?
While some barriers still need to be cleared, machine-learning technologies...Read more on AuntMinnie.comRelated Reading:
Group uses AI to assess mammo interpretation bias
SNMMI: AI enables stress-first SPECT MPI protocol
SNMMI: AI can avoid patient misidentification on PET/CT
SNMMI: AI can predict survival in sarcoma patients
How should AI be used in breast ultrasound? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 29, 2018 Category: Radiology Source Type: news
SNMMI: AI enables stress-first SPECT MPI protocol
PHILADELPHIA - Artificial intelligence (AI) analysis of stress SPECT myocardial...Read more on AuntMinnie.comRelated Reading:
SNMMI: Early prostate cancer therapy extends lives
SNMMI: New therapy aids patients with neuroendocrine tumors
SNMMI: AI can predict survival in sarcoma patients
SNMMI 2018: A year of promotion and ongoing challenges
ASNC releases new guidelines for SPECT MPI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 27, 2018 Category: Radiology Source Type: news
SNMMI: Early prostate cancer therapy extends lives
PHILADELPHIA - Providing lutetium-177 prostate-specific membrane antigen radioligand...Read more on AuntMinnie.comRelated Reading:
Annals: Overdiagnosis must be better defined
SNMMI: New therapy aids patients with neuroendocrine tumors
SNMMI: AI can predict survival in sarcoma patients
SNMMI 2018: A year of promotion and ongoing challenges
Faster MRI protocol avoids unneeded prostate biopsies (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 26, 2018 Category: Radiology Source Type: news
Live from SNMMI 2018: Nuclear medicine appropriate use
What's the best way to promote appropriate use of nuclear medicine? Dr. Sukhjeet...Read more on AuntMinnie.comRelated Reading:
SNMMI: AI can avoid patient misidentification on PET/CT
SNMMI: New therapy aids patients with neuroendocrine tumors
SNMMI: AI can predict survival in sarcoma patients
Live from SNMMI 2018: Securing the molybdenum supply
SNMMI 2018: A year of promotion and ongoing challenges (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 25, 2018 Category: Radiology Source Type: news
SNMMI: AI can predict survival in sarcoma patients
PHILADELPHIA - Artificial intelligence (AI) algorithms can help predict disease-free...Read more on AuntMinnie.comRelated Reading:
How should AI be used in breast ultrasound?
AI algorithm registers MRI scans in under 1 second
SIIM: AI can accurately detect cerebral microbleeds
Can AI reliably measure carotid intima-media thickness?
AI can detect, assess white-matter lesions on CT scans (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 25, 2018 Category: Radiology Source Type: news
Novel nuclear medicine approach shows promise for treating wide array of cancerous tumors
(Society of Nuclear Medicine and Molecular Imaging) A novel nuclear medicine approach is showing great promise for precision treatment of solid tumors in many types of cancer--including lung, breast, pancreas and ovarian in adults and glioma, neuroblastoma and sarcoma in children. The research was presented today at the SNMMI 2018 Annual Meeting, June 23-26 in Philadelphia. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 25, 2018 Category: Cancer & Oncology Source Type: news
PharmaEngine Announces Positive Topline Results from Global Pivotal Trial of PEP503 (NBTXR3) in Soft Tissue Sarcoma
TAIPEI, Taiwan, June 21, 2018 -- (Healthcare Sales & Marketing Network) -- PharmaEngine Inc. (TWO: 4162) and its corporate partner, Nanobiotix S.A. (Euronext: NANO) announced today that PEP503 (NBTXR3) in combination with radiotherapy met the primary endp... Biopharmaceuticals, Oncology PharmaEngine, Nanobiotix, soft tissue sarcoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 22, 2018 Category: Pharmaceuticals Source Type: news
Kaposi Sarcoma
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 21, 2018 Category: General Medicine Source Type: news
Results of Novel Mesothelioma Drug Presented at ASCO Meeting
A multicenter phase II clinical trial involving the latest orally administered protein inhibitor drug has shown considerable promise in helping control malignant mesothelioma.
The effectiveness of tazemetostat was presented last week at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago.
The trial study, which will conclude late 2018, involves 74 previously treated patients with recurring mesothelioma.
“We’ve seen benefit for some patients with this treatment and patients who have benefited over a long period of time,” medical oncologist Dr. Marianna Koczywas, City of Hope Cancer Treatment &am...
Source: Asbestos and Mesothelioma News - June 14, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news
